Fractures, Open
18
2
3
5
Key Insights
Highlights
Success Rate
45% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
33.3%
6 terminated out of 18 trials
45.5%
-41.1% vs benchmark
39%
7 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System
Acute Application of Antibiotic Powder in Open Fracture Wounds
AI Assisted Detection of Fractures on X-Rays (FRACT-AI)
Antibiotic Prophylaxis in Pediatric Open Fractures
LOQTEQ® Antibacterial Pre-Market Study
Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial
Tobramycin Injection to Prevent Infection in Open Fractures
The Treatment of Type I Open Fractures in Pediatrics
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
FastFrame Knee Spanning and Damage Control Kit PMCF
Powdered Intrawound Vancomycin in Open Fractures Trial
Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures
Ganga Hospital Scoring System In Type-IIIA/B Open Tibial Fractures
Cognitive Behavioural Therapy to Reduce Persistent Post-Surgical Pain After Fracture
Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Pilot
Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures
Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture
The New Skin Stretching Device for Treatment of Limb Tension Wounds